+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Predictive Disease Analytics - Global Strategic Business Report

  • PDF Icon

    Report

  • 214 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6106542
The global market for Predictive Disease Analytics was estimated at US$3.1 Billion in 2024 and is projected to reach US$10.4 Billion by 2030, growing at a CAGR of 22.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Predictive Disease Analytics market.

Global Predictive Disease Analytics Market - Key Trends & Drivers Summarized

How Is Predictive Disease Analytics Transforming the Future of Preventive Healthcare?

Predictive disease analytics is rapidly reshaping healthcare delivery by enabling early disease detection, forecasting outbreaks, and personalizing preventive care using data-driven algorithms. At the core of this transformation are machine learning models, statistical regression tools, and AI-based decision systems trained on vast datasets comprising electronic health records (EHRs), medical imaging, wearable sensor data, genomic profiles, and social determinants of health. These systems use pattern recognition and probabilistic modeling to identify individuals at elevated risk of developing chronic diseases such as diabetes, cardiovascular disorders, and cancer-often before symptoms appear.

Advanced platforms now integrate natural language processing (NLP) to extract clinical insights from unstructured physician notes and real-time monitoring data from wearable devices. Predictive tools also draw on longitudinal data to track disease progression and simulate treatment outcomes. For instance, in oncology, predictive models are used to determine tumor recurrence probabilities, while in cardiology, algorithms estimate risk for myocardial infarction based on lifestyle, vitals, and lipid profiles. The convergence of AI with personalized medicine is thus enabling more targeted screening, prioritizing care pathways, and reducing the economic burden of late-stage interventions.

In Which Areas Is Predictive Analytics Making the Deepest Clinical and Operational Impact?

Predictive analytics is having profound clinical applications across chronic disease management, mental health, infectious disease surveillance, and hospital operations. In diabetes care, predictive platforms analyze glucose patterns, dietary inputs, and medication adherence to forecast hypo- or hyperglycemic events. These insights enable proactive adjustments in insulin dosing or lifestyle interventions. In the area of mental health, AI models are being employed to predict depressive episode relapses or suicide risks based on behavioral trends from mobile apps, social media activity, and speech patterns.

In infectious disease control, predictive disease analytics played a vital role during the COVID-19 pandemic, forecasting outbreak hotspots, ICU occupancy, and transmission chains using mobility, contact-tracing, and weather data. These models are now being institutionalized in public health systems to prepare for future zoonotic outbreaks and seasonal influenza waves. At the operational level, hospitals use predictive tools to optimize resource allocation-forecasting bed occupancy, ER surges, readmission risks, and supply chain disruptions. Population health managers utilize these insights to segment patient cohorts, design outreach campaigns, and achieve risk-adjusted outcomes in accountable care environments.

How Are Data Integration, Ethics, and Regulation Shaping Adoption Trajectories?

The effectiveness and scalability of predictive disease analytics hinge on robust data integration and interoperability. Health systems are increasingly investing in Health Information Exchanges (HIEs), API-enabled data lakes, and federated data models that bring together structured and unstructured data from hospitals, labs, pharmacies, insurers, and remote monitoring tools. Cloud-native platforms and edge computing are enabling real-time data processing, especially in acute care settings. Genomic data integration, through partnerships with bioinformatics firms, is further enriching the predictive depth in oncology, rare disease, and pharmacogenomics applications.

However, ethical concerns surrounding data privacy, algorithmic bias, and explainability are shaping the regulatory framework. The General Data Protection Regulation (GDPR) in Europe, HIPAA in the U.S., and emerging data protection laws in India and Brazil are driving developers to implement strong encryption, anonymization, and data minimization techniques. Regulatory authorities are also evaluating predictive models under software-as-a-medical-device (SaMD) frameworks to ensure clinical validation and real-world reliability. Initiatives such as model transparency scores, clinical auditability, and bias mitigation strategies are becoming standard expectations for predictive analytics vendors. These developments are gradually fostering trust among clinicians and patients, catalyzing adoption across care ecosystems.

What Factors Are Fueling the Expansion of the Global Predictive Disease Analytics Market?

The growth in the global predictive disease analytics market is being fueled by rising chronic disease prevalence, increasing healthcare digitalization, and a paradigm shift toward value-based care models. Health systems are under pressure to improve outcomes while controlling costs, which is driving demand for tools that can identify high-risk individuals early and stratify intervention resources effectively. As aging populations and lifestyle-related diseases strain healthcare infrastructure, predictive analytics is proving essential in optimizing care delivery and extending healthy life expectancy.

Government support for digital health transformation-through policies such as the U.S. Cures Act, the EU Digital Health Strategy, and China's Health Informatization Plan-is incentivizing EHR adoption, AI investment, and predictive algorithm deployment. Simultaneously, the rise of health-focused wearables, mobile health apps, and remote patient monitoring (RPM) is feeding high-resolution behavioral and physiological data into predictive systems, improving accuracy and personalization. Pharmaceutical and insurance companies are leveraging predictive analytics to identify trial participants, monitor medication adherence, and manage population risk pools.

Strategic partnerships between health IT firms, academic medical centers, and AI startups are accelerating innovation pipelines and scaling pilot deployments across geographies. Major players such as IBM Watson Health, Health Catalyst, Optum, Philips, and SAS are expanding predictive portfolios through acquisitions and platform integrations. With rising pressure to contain healthcare costs, improve care outcomes, and personalize interventions, predictive disease analytics is expected to be a cornerstone of future health systems, with adoption accelerating in both high-income and developing countries.

Scope Of Study:

The report analyzes the Predictive Disease Analytics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Component (Software Component, Service Component, Hardware Component); Deployment (On-Premise Deployment, Cloud Deployment); End-Use (Healthcare Payer End-Use, Healthcare Providers End-Use, Other End-Uses)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Software Component segment, which is expected to reach US$6.8 Billion by 2030 with a CAGR of a 23.3%. The Service Component segment is also set to grow at 20.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $818.1 Million in 2024, and China, forecasted to grow at an impressive 21.0% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Predictive Disease Analytics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Predictive Disease Analytics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Predictive Disease Analytics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Ada Health GmbH, Aidoc, Behold.ai, Biofourmis, Clarify Health Solutions and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Predictive Disease Analytics market report include:

  • Ada Health GmbH
  • Aidoc
  • Behold.ai
  • Biofourmis
  • Clarify Health Solutions
  • CloudMedx
  • ConcertAI
  • Dascena
  • DeepMind Health (Google)
  • Eyenuk
  • GNS Healthcare
  • Health Catalyst
  • IBM Watson Health (Merative)
  • Jvion
  • KenSci
  • Lumiata
  • Medial EarlySign
  • Prognos Health
  • Tempus Labs
  • Zebra Medical Vision

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Predictive Disease Analytics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Focus on Preventive Healthcare and Early Diagnosis Spurs Demand for Predictive Analytics Tools
  • Integration of AI and Machine Learning Models Enhances Accuracy and Speed of Disease Forecasting
  • Surge in Chronic Disease Prevalence Throws the Spotlight on Predictive Risk Stratification Solutions
  • Expansion of Population Health Management Initiatives Strengthens Business Case for Analytics Adoption
  • OEM Partnerships With Payers and Providers Support Scalable Implementation in Clinical Settings
  • Increased Availability of Genomic and Biomarker Data Fuels Growth in Precision Predictive Tools
  • Government Investments in Digital Health Infrastructure Promote Widespread Analytics Adoption
  • Development of Cloud-Based Platforms for Scalable Predictive Modeling Enhances System Accessibility
  • Emergence of Real-Time Health Monitoring Devices Supports Dynamic and Adaptive Risk Scoring
  • Growth in Remote Patient Monitoring Programs Promotes Continuous Predictive Tracking
  • Use of Social Determinants of Health Data Expands Scope of Predictive Insights Beyond Clinical Factors
  • Focus on Reducing Hospital Readmissions and Emergency Visits Drives Preventive Analytics Integration
  • Regulatory Support for Value-Based Care Accelerates Outcomes-Focused Predictive Modeling
  • Expansion of AI-Driven Decision Support Systems Improves Workflow in Primary and Specialty Care
  • Data Interoperability and EHR Integration Challenges Drive Innovation in Unified Analytics Platforms
  • Rising Use of Predictive Tools in Epidemiology and Disease Surveillance Enhances Public Health Planning
  • Growth in Pharmaceutical R&D Adoption of Predictive Models Supports Trial Design and Risk Management
  • Development of Explainable AI Enhances Trust and Transparency in Clinical Use of Predictive Models
  • Adoption in Mental Health and Behavioral Analytics Expands Applications Beyond Traditional Domains
  • Market Expansion in Emerging Economies Promotes Localization and Regional Disease Pattern Modeling
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Predictive Disease Analytics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Predictive Disease Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Predictive Disease Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Predictive Disease Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Service Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for On-Premise Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Cloud Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Cloud Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Cloud Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Healthcare Payer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Healthcare Payer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Healthcare Payer End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Predictive Disease Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ada Health GmbH
  • Aidoc
  • Behold.ai
  • Biofourmis
  • Clarify Health Solutions
  • CloudMedx
  • ConcertAI
  • Dascena
  • DeepMind Health (Google)
  • Eyenuk
  • GNS Healthcare
  • Health Catalyst
  • IBM Watson Health (Merative)
  • Jvion
  • KenSci
  • Lumiata
  • Medial EarlySign
  • Prognos Health
  • Tempus Labs
  • Zebra Medical Vision

Table Information